Terms: = Liver cancer AND LDH AND Prognosis
111 results:
1. [The Value of Baseline PET/CT Imaging of Bone Marrow
Wang Y; Zhao M; Yuan L; Li J
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Apr; 32(2):439-444. PubMed ID: 38660849
[TBL] [Abstract] [Full Text] [Related]
2. Prognostic Value of Lactate Dehydrogenase in Patients with Melanoma Treated with Pembrolizumab.
Popović A; Petković I; Dimitrijevic A; Jović A
Acta Dermatovenerol Croat; 2023 Nov; 31(2):86-91. PubMed ID: 38006368
[TBL] [Abstract] [Full Text] [Related]
3. Circulating sNinj1 as a novel predictor of prognosis and severity in hepatocellular carcinoma.
Yan L; Su W; Gan D; Li D; Mai L; Wang B; Wang L; Peng L; Jiang L; Wang Z; Hu Q; Chen W
Clin Chim Acta; 2023 Oct; 550():117581. PubMed ID: 37802206
[TBL] [Abstract] [Full Text] [Related]
4. Assessing the prognostic value of IMDC risk score for nivolumab-treated patients with renal cancer and malignant melanoma.
Beypınar I; Sözel Y; Önder AH
Cancer Biomark; 2023; 38(3):367-377. PubMed ID: 37718781
[TBL] [Abstract] [Full Text] [Related]
5. Nomogram Based on liver Function Test Indicators for Survival Prediction in Nasopharyngeal Carcinoma Patients Receiving PD-1 Inhibitor Therapy.
Liang L; Li Y; Hong Y; Ji T; Chen H; Lin Z
Curr Oncol; 2023 Jul; 30(8):7189-7202. PubMed ID: 37623002
[TBL] [Abstract] [Full Text] [Related]
6. Differences in glucose metabolic activity in liver metastasis separates two groups of metastatic uveal melanoma patients with different prognosis.
Del Carpio LP; Algarra MA; Sabaté-Llobera A; Rodriguez-Vida A; Rossi-Seoane S; Ruiz S; Leiva D; Ramos E; Lladò L; Lorenzo D; Gutierrez C; Cortes-Romera M; Caminal JM; Piulats JM
Cancer Med; 2023 Jul; 12(13):14062-14071. PubMed ID: 37211960
[TBL] [Abstract] [Full Text] [Related]
7. Cathepsin H Knockdown Reverses Radioresistance of Hepatocellular Carcinoma via Metabolic Switch Followed by Apoptosis.
Chen Q; Qu S; Liang Z; Liu Y; Chen H; Ma S; Liu X
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982347
[TBL] [Abstract] [Full Text] [Related]
8. Prognostic value of serum α-HBDH levels in patients with lung cancer.
Yuan ZM; Wang LH; Chen C
World J Surg Oncol; 2023 Mar; 21(1):78. PubMed ID: 36872314
[TBL] [Abstract] [Full Text] [Related]
9. Carcinoembryonic antigen kinetics predict response to first-line treatment in metastatic colorectal cancer: Analysis from PRODIGE 9 trial.
Salfati D; Huot M; Aparicio T; Lepage C; Taieb J; Bouché O; Boige V; Phelip JM; Dahan L; Bennouna J; Le Malicot K; Boussari O; Gornet JM
Dig Liver Dis; 2023 Jun; 55(6):791-798. PubMed ID: 36725401
[TBL] [Abstract] [Full Text] [Related]
10. Conversion surgery for advanced hepatocellular carcinoma after combination treatment of lenvatinib and camrelizumab: a case report.
Chen Z; Chen Z; Fan W; Zou Y; Zhang Y; Shi N; Jin H
World J Surg Oncol; 2023 Jan; 21(1):29. PubMed ID: 36721173
[TBL] [Abstract] [Full Text] [Related]
11. Systemic Chemotherapy With or Without Hepatic Arterial Infusion Chemotherapy for liver Metastases From Pancreatic cancer: A Propensity Score Matching Analysis.
Ouyang H; Ma W; Si T; Liu D; Chen P; Gerdtsson AS; Song J; Ni Y; Luo J; Yan Z
Clin Colorectal Cancer; 2023 Mar; 22(1):111-119. PubMed ID: 36473779
[TBL] [Abstract] [Full Text] [Related]
12. Effect and outcomes analysis of anlotinib in non-small cell lung cancer patients with liver metastasis: results from the ALTER 0303 phase 3 randomized clinical trial.
Shen Y; Lu J; Hu F; Qian J; Zhang X; Zhong R; Zhong H; Chu T; Han B
J Cancer Res Clin Oncol; 2023 Apr; 149(4):1417-1424. PubMed ID: 35482076
[TBL] [Abstract] [Full Text] [Related]
13. Prognostic Factors in Patients with Advanced HER2-Positive Gastric cancer Treated with Trastuzumab-Based Chemotherapy: a Cohort Study.
Marshall S; Wakatsuki T; Takahari D; Matsushima T; Ishizuka N; Nakayama I; Osumi H; Ogura M; Ichimura T; Shinozaki E; Chin K; Yamaguchi K
J Gastrointest Cancer; 2023 Jun; 54(2):475-484. PubMed ID: 35435573
[TBL] [Abstract] [Full Text] [Related]
14. Protein arginine methyltransferase 3 promotes glycolysis and hepatocellular carcinoma growth by enhancing arginine methylation of lactate dehydrogenase A.
Lei Y; Han P; Chen Y; Wang H; Wang S; Wang M; Liu J; Yan W; Tian D; Liu M
Clin Transl Med; 2022 Jan; 12(1):e686. PubMed ID: 35090076
[TBL] [Abstract] [Full Text] [Related]
15. Prognostic nomogram for patients with unresectable pancreatic cancer treated with gemcitabine plus nab-paclitaxel or FOLFIRINOX: A post-hoc analysis of a multicenter retrospective study in Japan (NAPOLEON study).
Shibuki T; Mizuta T; Shimokawa M; Koga F; Ueda Y; Nakazawa J; Komori A; Otsu S; Arima S; Fukahori M; Makiyama A; Taguchi H; Honda T; Mitsugi K; Nio K; Ide Y; Ureshino N; Shirakawa T; Otsuka T
BMC Cancer; 2022 Jan; 22(1):19. PubMed ID: 34980029
[TBL] [Abstract] [Full Text] [Related]
16. Value of pretreatment serum lactate dehydrogenase as a prognostic and predictive factor for small-cell lung cancer patients treated with first-line platinum-containing chemotherapy.
He M; Chi X; Shi X; Sun Y; Yang X; Wang L; Wang B; Li H
Thorac Cancer; 2021 Dec; 12(23):3101-3109. PubMed ID: 34725930
[TBL] [Abstract] [Full Text] [Related]
17. Efficacy and safety of atezolizumab, in combination with etoposide and carboplatin regimen, in the first-line treatment of extensive-stage small-cell lung cancer: a single-center experience.
Lee S; Shim HS; Ahn BC; Lim SM; Kim HR; Cho BC; Hong MH
Cancer Immunol Immunother; 2022 May; 71(5):1093-1101. PubMed ID: 34568975
[TBL] [Abstract] [Full Text] [Related]
18. Changes in serum lactate dehydrogenase levels as markers of pathological response and prognosis in colorectal liver metastases patients receiving neoadjuvant chemotherapy followed by resection.
Chen J; Chen Q; Yao J; Jiang Y; Zhou J; Zhao H; Cai J
Ann Palliat Med; 2021 Oct; 10(10):10276-10292. PubMed ID: 34551571
[TBL] [Abstract] [Full Text] [Related]
19. Potent antitumor activity of a glutamyltransferase-derived peptide via an activation of oncosis pathway.
Fang C; Li W; Yin R; Zhu D; Liu X; Wu H; Wang Q; Wang W; Bai Q; Chen B; Yao X; Chen Y
Sci Rep; 2021 Aug; 11(1):16507. PubMed ID: 34389740
[TBL] [Abstract] [Full Text] [Related]
20. Taurine Upregulates miRNA-122-5p Expression and Suppresses the Metabolizing Enzymes of Glycolytic Pathway in Hepatocellular Carcinoma.
Nabi AA; Atta SA; El-Ahwany E; Elzayat E; Saleh H
Mol Biol Rep; 2021 Jul; 48(7):5549-5559. PubMed ID: 34313924
[TBL] [Abstract] [Full Text] [Related]
[Next]
